147 related articles for article (PubMed ID: 37001593)
1. Health consequences of mutant cartilage oligomeric matrix protein and its relationship to abnormal growth and joint degeneration.
Hecht JT; Chiu F; Veerisetty A; Hossain M; Posey KL
Matrix Biol; 2023 May; 119():101-111. PubMed ID: 37001593
[TBL] [Abstract][Full Text] [Related]
2. Joint Degeneration in a Mouse Model of Pseudoachondroplasia: ER Stress, Inflammation, and Block of Autophagy.
Hecht JT; Veerisetty AC; Hossain MG; Patra D; Chiu F; Coustry F; Posey KL
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502142
[TBL] [Abstract][Full Text] [Related]
3. CurQ+, a Next-Generation Formulation of Curcumin, Ameliorates Growth Plate Chondrocyte Stress and Increases Limb Growth in a Mouse Model of Pseudoachondroplasia.
Hecht JT; Veerisetty AC; Hossain MG; Chiu F; Posey KL
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835255
[TBL] [Abstract][Full Text] [Related]
4. Mutant cartilage oligomeric matrix protein (COMP) compromises bone integrity, joint function and the balance between adipogenesis and osteogenesis.
Coustry F; Posey KL; Maerz T; Baker K; Abraham AM; Ambrose CG; Nobakhti S; Shefelbine SJ; Bi X; Newton M; Gawronski K; Remer L; Veerisetty AC; Hossain MG; Chiu F; Hecht JT
Matrix Biol; 2018 Apr; 67():75-89. PubMed ID: 29309831
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues.
Hecht JT; Deere M; Putnam E; Cole W; Vertel B; Chen H; Lawler J
Matrix Biol; 1998 Aug; 17(4):269-78. PubMed ID: 9749943
[TBL] [Abstract][Full Text] [Related]
6. Early Resveratrol Treatment Mitigates Joint Degeneration and Dampens Pain in a Mouse Model of Pseudoachondroplasia (PSACH).
Hecht JT; Veerisetty AC; Patra D; Hossain MG; Chiu F; Mobed C; Gannon FH; Posey KL
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892235
[TBL] [Abstract][Full Text] [Related]
7. Chondrocyte-specific pathology during skeletal growth and therapeutics in a murine model of pseudoachondroplasia.
Posey KL; Coustry F; Veerisetty AC; Liu P; Alcorn JL; Hecht JT
J Bone Miner Res; 2014; 29(5):1258-68. PubMed ID: 24194321
[TBL] [Abstract][Full Text] [Related]
8. A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia.
Suleman F; Gualeni B; Gregson HJ; Leighton MP; Piróg KA; Edwards S; Holden P; Boot-Handford RP; Briggs MD
Hum Mutat; 2012 Jan; 33(1):218-31. PubMed ID: 22006726
[TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic interventions for pseudoachondroplasia.
Posey KL; Hecht JT
Bone; 2017 Sep; 102():60-68. PubMed ID: 28336490
[TBL] [Abstract][Full Text] [Related]
10. Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes.
Hecht JT; Montufar-Solis D; Decker G; Lawler J; Daniels K; Duke PJ
Matrix Biol; 1998 Dec; 17(8-9):625-33. PubMed ID: 9923655
[TBL] [Abstract][Full Text] [Related]
11. Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP.
Piróg-Garcia KA; Meadows RS; Knowles L; Heinegård D; Thornton DJ; Kadler KE; Boot-Handford RP; Briggs MD
Hum Mol Genet; 2007 Sep; 16(17):2072-88. PubMed ID: 17588960
[TBL] [Abstract][Full Text] [Related]
12. An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype.
Posey KL; Veerisetty AC; Liu P; Wang HR; Poindexter BJ; Bick R; Alcorn JL; Hecht JT
Am J Pathol; 2009 Oct; 175(4):1555-63. PubMed ID: 19762713
[TBL] [Abstract][Full Text] [Related]
13. Pseudoachondroplasia/COMP - translating from the bench to the bedside.
Posey KL; Alcorn JL; Hecht JT
Matrix Biol; 2014 Jul; 37():167-73. PubMed ID: 24892720
[TBL] [Abstract][Full Text] [Related]
14. Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes.
Hecht JT; Hayes E; Snuggs M; Decker G; Montufar-Solis D; Doege K; Mwalle F; Poole R; Stevens J; Duke PJ
Matrix Biol; 2001 Jul; 20(4):251-62. PubMed ID: 11470401
[TBL] [Abstract][Full Text] [Related]
15. Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes.
Merritt TM; Bick R; Poindexter BJ; Alcorn JL; Hecht JT
Am J Pathol; 2007 Jan; 170(1):293-300. PubMed ID: 17200202
[TBL] [Abstract][Full Text] [Related]
16. Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype.
Merritt TM; Alcorn JL; Haynes R; Hecht JT
J Orthop Res; 2006 Apr; 24(4):700-7. PubMed ID: 16514635
[TBL] [Abstract][Full Text] [Related]
17. Cartilage oligomeric matrix protein: COMPopathies and beyond.
Posey KL; Coustry F; Hecht JT
Matrix Biol; 2018 Oct; 71-72():161-173. PubMed ID: 29530484
[TBL] [Abstract][Full Text] [Related]
18. Identification of twelve mutations in cartilage oligomeric matrix protein (COMP) in patients with pseudoachondroplasia.
Deere M; Sanford T; Ferguson HL; Daniels K; Hecht JT
Am J Med Genet; 1998 Dec; 80(5):510-3. PubMed ID: 9880218
[TBL] [Abstract][Full Text] [Related]
19. Abnormal chondrocyte apoptosis in the cartilage growth plate is influenced by genetic background and deletion of CHOP in a targeted mouse model of pseudoachondroplasia.
Piróg KA; Irman A; Young S; Halai P; Bell PA; Boot-Handford RP; Briggs MD
PLoS One; 2014; 9(2):e85145. PubMed ID: 24558358
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant and anti-inflammatory agents mitigate pathology in a mouse model of pseudoachondroplasia.
Posey KL; Coustry F; Veerisetty AC; Hossain M; Alcorn JL; Hecht JT
Hum Mol Genet; 2015 Jul; 24(14):3918-28. PubMed ID: 25859006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
